← All claims

Longevity & Aging · Diets · Metabolic & Cardiometabolic

caloric restriction improves cardiometabolic risk factors

In plain terms: Does eating fewer calories improve heart and blood-sugar health?

Strong support Longevity & Aging 🔬 Includes disconfirming

Part of: • Insulin & Metabolic Aging

RefutedContestedStrong support
consensus score 0.68

Yes, though it improves risk markers (not proven lifespan) and benefits fade if weight returns.

📅 Last reviewed: 2026-07-15

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

18 support 1 contradict 0 tested null 4 mixed · 23 sources, 18 independent groups

What the evidence shows

Two years of caloric restriction improved cardiometabolic risk factors and slowed an epigenetic pace-of-aging measure in healthy non-obese humans (CALERIE) - the strongest human design here, but surrogate endpoints only; it does NOT prove CR extends human lifespan, and benefits reverse with weight regain.

The evidence (23)

SourceGradeStanceQualityFinding
Nasrollahzadeh
2023 · Int J Endocrinol Metab
RCT supports moderate Reduced-calorie diet lowered inflammatory and metabolic factors in overweight/obese with cardiovascular risk factors.
Warmbrunn MV et al
2026 · Nature Communications
RCT supports high CALERIE-2 mechanistic sub-study (24-month RCT, non-obese adults); CR increased HMW adiponectin and reduced ceramides (C16:0, C18:0, C24:0) linked to insulin resistance, partially mediating improved insulin sensitivity/secretion; effects att
Werndle VV et al
2026 · study_type: meta-analysis
meta-analysis supports moderate Systematic review/meta-analysis, 46 studies, 12,128 participants; diet-only intervention reduced MetS z-score by -0.72 units (17 arms, p<0.001) and consistently improved fasting glucose, triglycerides, HDL, waist circumference, and blood pr
Ryan CP, et al.
2025 · Nat Aging
RCT supports moderate CALERIE multi-omics: CR slowed DunedinPACE epigenetic aging
Maroofi
2020 · Lipids Health Dis
RCT supports moderate Intermittent vs continuous CR both improved body weight and cardiometabolic markers in overweight hypertriglyceridemic subjects.
Warmbrunn MV et al
2026 · study_type: RCT
RCT mixed high CALERIE-2 post-hoc (n=190): sustained CR-induced weight loss maintained improvements in insulin AUC and IGF-1/IGFBP-1 ratio and lower biological age; weight regain (>5%) reversed these insulin-IGF-1 pathway benefits.
Houston DK et al
2026 · study_type: RCT
RCT supports low HALLO-P: 90 older adults (60+) randomized to 20% CR in-person, remote CR, or TRE for 9 months; CR/RCR lost 4.4-6.7kg fat+lean mass, and glucose and cholesterol improved in all 3 groups despite CR target not fully achieved (actual CR only 4.
Wei Z et al
2024 · study_type: observational
observational supports low Narrative review of CR-Sirtuin-cardiovascular mechanistic literature; asserts CR benefits CVS via sirtuin pathways but presents no new primary human outcome data, mechanism/animal evidence only cited.
Schroor
2024 · Adv Nutr
meta-analysis mixed moderate Meta-analysis: intermittent energy restriction comparable to continuous on weight/cardiometabolic markers; benefits largely weight-mediated.
Trouwborst
2021 · Nutrients
observational supports moderate 8-wk LCD improved cardiometabolic risk factors with weight loss; partly maintained at 6mo
Semnani-Azad 2025
2025 · BMJ
meta-analysis supports moderate Network MA of RCTs: continuous energy restriction improved intermediate cardiometabolic outcomes vs ad-lib
⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction
Most
2018 · Am J Physiol Endocrinol Metab
RCT supports high 25% CR over 24mo improved cardiometabolic risk (BP, lipids, insulin) in healthy nonobese adults
Li Y et al
2026 · study_type: RCT
RCT supports moderate CardioMetAge aging-clock study (NHANES/UK Biobank derivation + validation); two-year caloric restriction intervention (CALERIE) slowed CardioMetAge progression by 1.23 years (95% CI 0.61-1.84) relative to ad libitum control.
Peters
2025 · Sci Transl Med
RCT contradicts high Isocaloric time-restricted eating shifted circadian clocks but did NOT improve insulin sensitivity/cardiometabolic risk; benefit needs calorie deficit.
Duszka K et al
2020 · study_type: observational
observational mixed low Narrative review on CR-PPAR shared pathways affecting metabolism/health/longevity; summarizes mechanistic literature only, no primary cardiometabolic outcome data presented.
Sedej S et al
2025 · study_type: animal
animal supports moderate Mouse model of obesity-related HFpEF; genetic/pharmacologic ATGL inhibition (atglistatin) in adipose tissue improved diastolic dysfunction and lowered adipose IL-1β more effectively than caloric restriction, which showed only partial benefi
Åberg S et al
2026 · study_type: RCT
RCT supports moderate 12-week RCT, 229 completers with overweight/obesity on hypocaloric diets (wholegrain rye vs refined wheat); both groups lost similar weight, but the rye group had a 17% CRP reduction; baseline HOMA-IR/CRP correlated with fat-mass change.
Dhana K et al
2025 · study_type: RCT
observational supports moderate MIND trial (n=518 overweight/obese adults 65-84), 3-year mild CR (250kcal) diet; >10% weight loss vs no loss produced LDL -8.3%, triglycerides -28.2%, HDL +12.4%, hs-CRP -59.4%, adiponectin +53.7%, independent of which diet arm.
Ikizler
2018 · J Am Soc Nephrol
RCT supports moderate Caloric restriction (+/-exercise) in moderate-severe CKD improved proinflammatory metabolic milieu and fat mass.
Kraus WE, et al. (CALERIE-2)
2019 · Lancet Diabetes Endocrinol
RCT supports moderate CALERIE-2 RCT n=218: ~12% CR x2y improved LDL, BP, CRP, insulin sensitivity, MetS score
Leal
2022 · Antioxidants
RCT mixed low Energy restriction vs atorvastatin in women with premature CAD: CR affected LDL and HDL function but less than statin.
Stekovic
2019 · Cell Metab
RCT supports moderate Alternate-day fasting (~37% calorie cut) improved cardiovascular markers, reduced LDL, sICAM-1, trunk fat in healthy adults.
Laysandro R et al
2026 · study_type: observational
n-of-1 supports low Case report: one 43-year-old man with severe CAD/obesity underwent 10-month supervised large caloric deficit + high protein diet + exercise; lost 50kg, HDL rose, HbA1c fell, BP improved, but LDL/total cholesterol rose.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.